UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 6, 2021
Accession Number:
Submission Type:
CIK:
0001815974
Company Name:
Anebulo Pharmaceuticals, Inc.
File Number:
333-254979